Science-focused product line is backed by global cannabis leader Panaxia Pharmaceutical Industries
LOS ANGELES – DECEMBER 10, 2019 – Ocean Grown Ventures (the “Company”), a science-focused cannabis company offering wellness solutions that meet pharmaceutical manufacturing standards, today announced the launch of ‘Tikva’, a full-spectrum hemp-derived CBD product line, designed to provide consumers consistent and high quality health and wellness offerings.
Tikva – derived from the Hebrew word for ‘hope’ – offers formulations created and manufactured by global medical cannabis leader Panaxia Pharmaceutical Industries (“Panaxia”) via a partnership with Ocean Grown Ventures. Panaxia’s experience in the broader cannabis space involves more than 10 years of world-class research, clinical studies, and groundbreaking scientific innovations in medical cannabis.
The Company’s product commercialization and manufacturing also meets stringent current Good Manufacturing Practices (GMP) for their facilities and processes, ensuring the most accurate and consistent dosing for reliable relief.
“As a science-first brand, Tikva offers consumers some of the highest quality CBD health and wellness products available,” said Jerry Katz, founder and chief executive officer of Ocean Grown Ventures. “The biggest issues in the current marketplace are consistency and accuracy – but Tikva’s science-driven innovation and research-backed formulations offer wellness products in a class of their own.”
Tikva’s portfolio is initially offering full-spectrum hemp-based CBD formulations, with plans for a THC line soon after. Products currently available include:
- Full-Spectrum Hemp CBD Oral Tablets
- Myo-Inositol Full-Spectrum Hemp CBD Tablets
- Melatonin Full-Spectrum Hemp CBD Tablets
- Full-Spectrum Hemp CBD Tincture Oil
Tikva’s Full-Spectrum Hemp CBD Relief Cream will be available starting in early 2020.
These can be purchased by U.S. consumers over the age of 18 via Tikva’s e-commerce website tikvahealth.com and via select health practitioners.
“We want to take the guesswork out of alternative wellness treatments, and with Panaxia’s unmatched research and development, we’re able to bring that to the U.S. market,” said Katz. “We thoroughly believe Tikva’s personalized product offerings will prove a gamechanger for those seeking a scientific approach to medical cannabis.”
About Ocean Grown Ventures Ocean Grown Ventures (the “Company”) offers the highest quality cannabis-derived wellness solutions to the U.S. market and beyond by meeting standards usually reserved for pharmaceutical companies. Through its exclusive partnership with renowned Israeli pharmaceutical pioneer Panaxia Pharmaceutical Industries, Ocean Grown Ventures has sales and distribution rights to consistent and proprietary formulations that meet current Good Manufacturing Practices (GMP) standards. The Company applies Panaxia’s world-class scientific expertise to develop and market formulations that offer customized and accessible solutions. Ocean Grown Ventures is headquartered in Los Angeles, California. For more information, or to inquire about white-label opportunities, please visit Ocean Grown Ventures’ website at OceanGrownVentures.com.
Natalie Katz, for Ocean Grown Ventures
+ 1 (310) 702-2659
Joel Labi, for Ocean Grown Ventures
+ 1 (917) 415-5666